Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
Clinical trial NCT03839355 · TERMINATED
Trial details
- NCT number
- NCT03839355
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2020-12-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.